Early pulmonary inflammation in infants with cystic fibrosis, Am J Respir Crit Care Med, vol.151, pp.1075-82, 1995. ,
Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients, Am J Respir Crit Care Med, vol.160, pp.186-91, 1999. ,
Early inflammation in the airways of a cystic fibrosis foetus, J Cyst Fibros, vol.6, pp.304-312, 2007. ,
Essential fatty acid deficiency in well nourished young cystic fibrosis patients, Eur J Pediatr, vol.156, pp.952-958, 1997. ,
Persistence of essential fatty acid deficiency in cystic fibrosis despite nutritional therapy, Pediatr Res, vol.66, pp.585-594, 2009. ,
Persistent fat malabsorption in cystic fibrosis; lessons from patients and mice, J Cyst Fibros, vol.10, pp.150-158, 2011. ,
Nutrition in patients with cystic fibrosis: a European Consensus, J Cyst Fibros, vol.1, pp.51-75, 2002. ,
Beneficial effects of n-3 PUFA on chronic airway inflammatory diseases, Prostaglandins Other Lipid Mediat, vol.99, pp.57-67, 2012. ,
Omega-3 fatty acids for cystic fibrosis, Cochrane Database Syst Rev, vol.11, p.2201, 2013. ,
Increased tissue arachidonic acid and reduced linoleic acid in a mouse model of cystic fibrosis are reversed by supplemental glycerophospholipids enriched in docosahexaenoic acid, J Nutr, vol.139, pp.2358-64, 2009. ,
n-3) longchain PUFA differentially affect resistance to Pseudomonas aeruginosa infection of male and female cftr-/-mice, J Nutr, vol.141, pp.1101-1108, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-02178838
Dietary (n-3) polyunsaturated fatty acids affect the kinetics of pro-and antiinflammatory responses in mice with Pseudomonas aeruginosa lung infection, J Nutr, vol.139, pp.82-91, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-02178624
A mouse model for the cystic fibrosis delta F508 mutation, EMBO J, vol.14, pp.4403-4414, 1995. ,
Dietary n-3 fatty acids have suppressive effects on mucin upregulation in mice infected with Pseudomonas aeruginosa, Respir Res, vol.11, pp.1-11, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-02178627
TACI-Ig prevents the development of airway hyperresponsiveness in a murine model of asthma, Clin Exp Allergy, vol.38, pp.1959-68, 2008. ,
Understanding interobserver agreement: the kappa statistic, Fam Med, vol.37, pp.360-363, 2005. ,
Modulation of host defence against bacterial and viral infections by omega-3 polyunsaturated fatty acids, J Infect, vol.73, pp.523-558, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02178827
An animal model for cystic fibrosis made by gene targeting, Science, vol.257, pp.1083-1091, 1992. ,
A mouse model for the delta F508 allele of cystic fibrosis, J Clin Invest, vol.96, pp.2051-64, 1995. ,
Early childhood growth in patients with cystic fibrosis, Ann Hum Biol, vol.17, pp.483-99, 1990. ,
Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis, J Pediatr, vol.142, pp.624-654, 2003. ,
Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: Analysis of the Cystic Fibrosis Foundation National CF Patient Registry, J Pediatr, vol.137, pp.374-80, 2000. ,
Mouse as a model of growth retardation in cystic fibrosis, Pediatr Res, vol.59, pp.191-196, 2006. ,
Immunomodulatory activity of vardenafil on induced lung inflammation in cystic fibrosis mice, J Cyst Fibros, vol.11, pp.266-73, 2012. ,
Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice, Respir Res, vol.7, p.134, 2006. ,
Lung inflammation in cystic fibrosis: pathogenesis and novel therapies, Clin Biochem, vol.47, pp.539-585, 2014. ,
Nasal and bronchoalveolar lavage fluid cytokines, J Infect Dis, vol.175, pp.638-685, 1997. ,
Characterization of LPS-induced lung inflammation in cftr-/-mice and the effect of docosahexaenoic acid, J Appl Physiol, vol.92, pp.2169-76, 2002. ,
Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells, Am J Respir Cell Mol Biol.spirCell MolBiol, vol.41, pp.199-206, 2009. ,
Expression of S100A8 correlates with inflammatory lung disease in congenic mice deficient of the cystic fibrosis transmembrane conductance regulator, Respir Res, vol.7, p.51, 2006. ,
Mouse models of cystic fibrosis: phenotypic analysis and research applications, European Cystic Fibrosis Society, vol.10, pp.152-71, 2011. ,
Increased susceptibility of cftr-/-mice to LPS-induced lung remodeling, vol.310, pp.711-720, 2016. ,
Lipoxin A4 and platelet activating factor are involved in E. coli or LPS-induced lung inflammation in CFTR-deficient mice, PLoS One, vol.9, p.93003, 2014. ,
Role of IL-1?? in experimental cystic fibrosis upon P. aeruginosa Infection, PLoS One, vol.9, pp.1-17, 2014. ,
Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa, J Clin Invest, vol.100, pp.2810-2815, 1997. ,
A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice, Proc Natl Acad Sci U S A, vol.96, pp.13995-4000, 1999. ,
Association of cystic fibrosis with abnormalities in fatty acid metabolism, N Engl J Med, vol.350, pp.560-569, 2004. ,
Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis, Am J Respir Cell Mol Biol, vol.41, pp.590-602, 2009. ,
PPARalpha downregulates airway inflammation induced by lipopolysaccharide in the mouse, Respir Res, vol.6, p.91, 2005. ,
URL : https://hal.archives-ouvertes.fr/inserm-00090225
PPAR-? activation reduced LPS-induced inflammation in alveolar epithelial cells, Exp Lung Res, vol.41, pp.393-403, 2015. ,
Peroxisome proliferator-activated receptor alpha (PPAR alpha) down-regulation in cystic fibrosis lymphocytes, Respir Res, vol.7, p.104, 2006. ,
Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis, Prostaglandins Leukot Essent Fat Acids, vol.77, pp.309-327, 2007. ,
Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis, J Pediatr, vol.139, pp.650-655, 2001. ,